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Abstract: Pseudomonas tolaasii, P. reactans and Burkholderia gladioli pv. agaricicola, are responsible of diseases on some 
species of cultivated mushrooms. The main bioactive metabolites produced by both Pseudomonas strains are the lipodepsip-
eptides (LDPs) tolaasin I and II and the so called White Line Inducing Principle (WLIP), respectively, LDPs which have been 
extensively studied for their role in the disease process and for their biological properties. In particular, their antimicrobial 
activity and the alteration of biological and model membranes (red blood cell and liposomes) was established. In the case of 
tolaasin I interaction with membranes was also related to the tridimensional structure in solution as determined by NMR com-
bined with molecular dynamic calculation techniques. Recently, ﬁ  ve news minor tolaasins, tolaasins A-E, were isolated from 
the culture ﬁ  ltrates of P. tolaasii and their chemical structure was determined by extensive use of NMR and MS spectroscopy. 
Furthermore, their antimicrobial activity was evaluated on target micro-organisms (fungi—including the cultivated mushrooms 
Agaricus bisporus, Lentinus edodes, and Pleurotus spp.—chromista, yeast and bacteria). The Gram positive bacteria resulted 
the most sensible and a signiﬁ  cant structure-activity relationships was apparent. The isolation and structure determination of 
bioactive metabolites produced by B. gladioli pv. agaricicola are still in progress but preliminary results indicate their peptide 
nature. Furthermore, the exopolysaccharide (EPS) from the culture ﬁ  ltrates of B. gladioli pv. agaricicola, as well as the O-chain 
and lipid A, from the lipo-polysaccharide (LPS) of the three bacteria, were isolated and the structures determined. 
Keywords: cultivated mushrooms and bacterial diseases, Pseudomonas tolaasii, P. reactans and Burkholderia gladioli pv. 
agaricicola, lipodepsipetides, mycopathogenic bacteria, antimicrobial activity, permeabilising effects on membranes, exo-
polysaccharides and lipo-polysaccharides
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Introduction
Brown blotch of Agaricus bisporus (Lange) Imbach 
(Tolaas, 1915) and the yellowing of Pleurotus ostreatus 
(Jacq.: Fr.) Kum (Ferri, 1985, pp 398; Iacobellis and 
Lo Cantore, 1997; Iacobellis and Lo Cantore, 1998a) 
are important diseases of the above cultivated mush-
rooms known to be caused by Pseudomonas tolaasii 
(Paine, 1919). However, recent studies have shown 
that the above diseases are complex ones. In particu-
lar, besides P. tolaasii also P. reactans, a saprotroph 
associated with cultivated mushrooms not yet clas-
siﬁ  ed and known in bibliography for its use in the 
white line assay for the speciﬁ  c identiﬁ  cation of P. 
tolaasii (Wong and Preece, 1979), is responsible, 
though in different manner, of the symptom develop-
ment on the hosts. Furthermore, P. reactans, has been 
shown to be the casual agent of the yellowing of P. 
eryngii (D.C.: Fr.) Quél a mushroom species culti-
vated in southern Italy (Iacobellis and Lo Cantore, 
1997; Iacobellis and Lo Cantore, 1998b; Lo Cantore, 
2001; Lo Cantore and Iacobellis, 2002; Iacobellis and 
Lo Cantore, 2003). The pathogenicity of P. reactans 
may be considered a novelty though indications in 
this regard have been reported in independent studies 
(Kim et al. 1995; Wells et al. 1996).
Burkholderia gladioli pv. agaricicola is the causal 
agent of the soft rot disease of the edible mushroom 
A. bitorquis on which it cause the rapid development 
of deep oozing lesions on the pileus which renders 
the mushroom unmarketable (Atkey et al. 1991, 
p 431; Lincoln et al. 1991). The disease appear 
geographically limited since it has been reported ﬁ  rst 
in England (Lincoln et al. 1991) and then in New 
Zealand (Gill and Cole, 1992) on A. bitorquis. 
Preliminary analysis of the partially purified 
antimicrobial metabolites produced by of B. gladioli 
pv. agaricicola indicate their peptide nature. After that, 
the disease was reported on several common Japanese 
cultivated mushroom (Gill and Tsuneda, 1997).
Isolation of Tolaasin I from Culture 
Filtrate of Pseudomonas tolaasii
Virulent strains of phytopathogenic as well as 
mycopathogenic Pseudomonas spp. produce 83
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in vitro toxic and antimicrobial lipodepsipeptides 
(LDPs) containing unusual aminoacids also with 
a D-stereochemistry and are classified in two 
groups according to their primary structures. The 
first group includes nonapeptides such as 
syringomycins (Fig. 1), syringotoxins, syringostatins 
and pseudomycins. The second group comprises 
molecules containing 18 to 25 amino acid residues, 
most of which having a D-stereochemistry, such as 
syringopeptins (Fig. 2), tolaasins, fuscopeptins and 
corpeptins, (Bender et al. 1999). In the latter group 
the C-terminal region forms a lactone ring of 5 
(tolaasins, fuscopeptins and corpeptins) to 8 
(syringopeptins) amino acids.
Tolaasin I (8, Fig. 3), a lipodepsipeptide pro-
duced in culture by virulent strains of P. tolaasii 
(Rainey et al. 1991), bears a β-OH octanoic acid 
blocking group at the N-terminus, a sequence of 
seven successive D-amino acids in the N-terminal 
region of the peptide (Pro 2 -Val 8), with a Ser-
Leu-Val repeat, and then alternate L- and D-amino 
acids (Nutkins et al. 1991) (Fig. 3). It also con-
tains a Z-dehydroalanine But) amino acid at posi-
tions 1 and 13, and a D-homoserine (Hse 16) and 
a D-2,4-diaminobutyric acid (D-Dab 17). Finally, 
a lactone ring is formed between the hydroxyl of 
D-Thr 14 and the C-terminal L-Lys 18.
Biological studies demonstrated that tolaasin I 
exhibits antimicrobial activity, strong resistance to 
enzymatic degradation and inactivation as well 
antigenicity (Rainey et al. 1991). This suggests for 
tolaasin I a potential role as a therapeutic peptide.
Tolaasin I is considered the main virulence fac-
tor of P. tolaasii and responsible for the symptoms 
development on the mushrooms (Rainey et al. 
1991; 1992; Soler-Rivas et al. 1999a) and this is 
apparently due to the ability of this molecule to 
disrupt cell membrane function by the transmem-
brane pore formation (Brodey et al. 1991; Rainey 
et al. 1991; Hutchinson and Johnstone, 1993). 
Tolaasin I was isolated from the cell-free bacterial 
culture ﬁ  ltrate of the type strain NCPPB2192 of 
P. tolaasii following a modiﬁ  cation of the method 
described by Peng (1996). The further puriﬁ  cation 
of the tolaasin I preparation by HPLC showed that 
P. tolaasii, besides the already known tolaasin I 
and II, which differ for the presence of Hse and 
Gly, respectively, in position 16, (Nutkins et al. 
1991), produced in vitro other chemical correlated 
metabolites conﬁ  rming previous ﬁ  ndings (Shirata 
et al. 1995). HPLC proﬁ  le of a crude tolaasin 
preparation (Fig. 4) carried out on an Analytical 
Brownlee Aquapore RP-300 (C8) column using 
water (0.1% TFA, v/v) and CH3CN as solvent 
system with a ﬂ  ow rates of 1.0 ml/min
-1 [a Brown-
lee Aquapore RP-300 (C8) column using the same 
solvent system with ﬂ  ow rate 4.7 ml/min was used 
for semipreparative purpose] showed the presence 
of ﬁ  ve minor peaks, named tolaasins A, B, C, D, 
and E (Bassarello et al. 2004).
The chemical nature of tolaasin I was ascertained 
by comparing its NMR and MS data with those 
reported in the literature (Nutkins et al. 1991).
Isolation of White Line Inducing 
Principle (WLIP) from Culture 
Filtrate of Pseudomonas reactans
Virulent strains of P. reactans produce in culture 
an extracellular substance called the White Line 
Inducing Principle (WLIP, 9, Fig. 5), known for 
its ability to interact with tolaasin I and form a 
white precipitates in the “white line” assay useful 
for the identiﬁ  cation of P. tolaasii (Wong and Pre-
ece, 1979). The ability of WLIP to precipitate 
tolaasin I, the main virulence factor of P. tolaasii, 
has been suggested to be useful for the control of 
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Figure 1. Structure of syringomicins A1, E and G (1, 2 and 3, 
respectively).84
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Figure 2. Structure of syringopeptins 22A, 22B, 25A and 25B (4, 5, 6 and 7, respectively).
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Figure 3. Tolaasin I (8) primary structure.
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Figure 4. HPLC proﬁ  le of crude tolaasins preparation.
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brown blotches caused by P. tolaasii (Soler-Rivas 
et al. 1999b). WLIP, whose biological features are 
substantially unknown, is a lipodepsipeptide with 
a molecular weight of 1125 Da composed of a 
N-terminal β-hydroxydecanoic acid and a peptite 
moiety of nine aminoacids, six of which of 
D-form. The molecule presents a lactone ring 
between D-allo-threonine (D-Thr3) and N-terminal 
L-isoleucine (Ileu9) (Mortischire-Smith et al. 
1991b). WLIP is structurally similar to viscosin 
(Laycock et al. 1991), except for the chirality of 
leucine in position 5 that it is D- in WLIP and L- in 
viscosin. This substance is a potent biosurfactant 
that appears important in the biology of the phy-
topathogenic bacterium P. ﬂ  uorescens (Neu et al. 
1990; Laycock et al. 1991).
The isolation and puriﬁ  cation of crude WLIP 
from the culture ﬁ  ltrates of strain NCPPB1311 of 
P. reactans was performed according to the proce-
dure reported by Mortishire-Smith et al. (1991b). 
Crude WLIP was obtained by fractionated precipi-
tation in acid conditions whereas crystalline WLIP 
was prepared by the diffusion of water vapour into 
a solution of crude WLIP in methanol.
The identity of WLIP was ascertained by 
comparing NMR and MS data with those reported 
in literature (Mortishire-Smith et al. 1991b). The 
determination of the absolute structure of the 
lipodepsipetide by X-ray analysis allowed to ruled 
out its supposed identity with viscosin from which 
differ in the form of the crystalline cell.
Strain NCPPB1311 of P. reactans produced in 
culture high levels of WLIP with a yield of 169 mg/l 
which was more than ten fold higher of tolaasin I 
(13 mg/l) produced by strain NCPPB2192 of P. 
tolaasii (Lo Cantore et al. 2006).
Biological Charaterization
of Tolaasin I and of WLIP
Antimicrobial activity of bacterial 
cultures and pure toxins
The antimicrobial assays of HCLP grade tolaasin I 
and crystalline WLIP conﬁ  rmed the antimicrobial 
activity of tolaasin I (Rainey et al. 1991; 1992) 
and showed that also WLIP is a lipodepsipeptide 
inhibiting the growth of bacteria and fungi 
(Tables 1 and 2) (Lo Cantore et al. 2006). In general 
tolaasin I showed an antimicrobial activity higher 
than WLIP. The Gram positive bacterium Bacillus 
megaterium resulted the most sensible micro-
organism to both tolaasin I and WLIP with a 
Minimal Inhibitory Quantity (M.I.Q) of 0.04 µg 
and 0.32 µg, respectively (Table 1). Also the other 
Gram positive bacteria used in this study were 
inhibited by both LPDs with M.I.Q signiﬁ  cantly 
different on Rhodococcus fascians and Curtobac-
trium ﬂ  accufaciens (Table 1). On the contrary the 
Gram negative bacteria, including Escherichia coli, 
were inhibited by tolaasin I but not by WLIP 
Table 1. Antimicrobial activity of tolaasin I and WLIP towards bacteria.
Bacteria  No strains  Minimal Inhibitory Quantity (µg)
   Tolaasin  I  WLIP
Gram positive    
Bacillus megaterium 1  0.04  0.32
Rhodococcus fascians 2  0.16  1.28
Clavibacter michiganensis subsp. michiganensis 2  0.32  0.64
C. michiganensis subsp. sepedonicus 1  0.32  0.64
Curtobacterium ﬂ  accunfaciens 1  0.16  0.64
Gram negative    
Escherichia coli 1  0.64  -
b
Pseudomonas tolaasii 1  -
a “
P. “reactans” 1  1.28  “
P. syringae pv. phaseolicola 1  1.28  “
P. corrugata 1  0.64  “
Agrobacterium tumefaciens 1  0.64  “
Erwinia herbicola 1  0.64  “
Xanthomonas campestris pv. phaseoli 1  1.28  “
ano inhibitory activity were observed with a quantity of tolaasin I equal at 1.28 µg.
bno inhibitory activity were observed with a quantity of WLIP equal at 10.24 µg.87
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(Table 1). It is of interest the fact that either cultures 
of strains NCPPB2192 or NCPPB1311 of P. tolaasii 
and P. reactans, respectively, inhibited the 
growth of E. coli K12 but only when the assays 
were performed on a minimal medium agar (MMA) 
(Lavermicocca et al. 1997). In fact, the above 
activity was not observed when the assays were 
performed on KB plates. The fact that the presence 
of the E. coli growth inhibiting metabolites was 
observed only on a minimal medium and the activ-
ity was reversed when peptone was added in the 
assay media suggest that either P. tolaasii and 
P. reactans produce besides tolaasins or WLIP, 
other metabolites, whose chemical nature and role 
in the biology of the producers should be investi-
gated. It is not excluded that also the above bacte-
ria produce metabolites similar to those produced 
by P. syringae strains involved in the inhibition of 
amino acids biosynthetic pathways (Bender et al. 
1999; Iacobellis and Latorraca, 1999; Arrebola 
et al. 2003; Cazorla et al. 2003).
In general, filamentous fungi, including 
A. bisporus, P. ostreatus, P. eryngii and Lentinus 
edodes, were inhibited by both LPDs but on 
average tolaasin I was about eight/ten fold more 
active than WLIP (Table 2).
Furthermore, tolaasin I inhibited the growth 
of Candida albicans and Cryptococcus 
neoformans, yeast-like fungi responsible of 
systemic and cutaneous mycoses in animals and 
humans but the sensibility was lower when 
compared to the ones shown by phytopathogenic 
fungi. On the contrary, in the assay condition no 
activity on the growth of C. parapsilosis (Ashford) 
or Malassezia pachydermatis was observed (Lo 
Cantore et al. 2006).
The results of this study conﬁ  rmed previous 
ﬁ  ndings on the toxicity of tolaasin I on fungi 
(Rainey et al. 1991; 1992) and clearly demonstrated 
that also WLIP, as other LPDs of bacterial origin 
(Bender et al. 1999), is toxic on fungi though in 
general its activity is lower than that showed by 
tolaasin I. The above ﬁ  ndings strongly suggest 
that also WLIP, as already reported for tolaasin I 
(Brodey et al. 1991; Rainey et al. 1991; 1992; 
Hutchison and Johnstone, 1993), is important in 
Table 2. Antimicrobial activity of tolaasin I and WLIP towards phytopathogenic fungi, chromista, yeast and ﬁ  la-
mentous fungi responsible for mycoses of mammalian, and cultivated mushrooms.
Micro-organisms  No strains  Minimal Inhibitory Quantity (µg)
   Tolaasin  I  WLIP
Fusarium solani 3  0.32  5.12
F. oxysporum 1  0.32  2.56
F. graminearum 1  0.16  -
a
Sclerotinia sclerotiorum 2  0.32  1.28
S. minor 1  0.16  0.64
Sclerotium rolfsii 1  0.32  -
a
Botrytis cinerea 2  0.16  1.28
Rhizoctonia solani 1  0.08  0.64
Verticillium dahliae 1  0.16  1.28
Trichoderma viride 1  0.16  1.28
Phytopthora nicotianae 1  0.32  -
a
P. citrophthora 1  0.32  -
a
Armillaria mellea 2  0.32  2.56
Heterobasidion annosum 2  0.16  1.28
Rhodotorula pilimanae 1  0.64  -
a
Candida albicans 1  5.12  -
b
C. parapsilosis 1  -
a “
Malassezia pachydermatis 1  -
a “
Cryptococcus neoformans 1  2.56 “
Agaricus bisporus 2  0.08  1.28
Pleurotus eryngii 3  0.32  2.56
P. ostreatus 2  0.16  1.28
Lentinus edodes 2  0.32  1.28
ano inhibitory activity were observed with a quantity of tolaasin I or WLIP equal to 10.24 µg.
bno inhibitory activity were observed with a quantity of WLIP equal at 25 µg.88
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the microbial interaction with mushrooms. In this 
respect, when considering the observed lower 
antifungal activity of WLIP it is also necessary 
to remind that strain NCPPB1311 of P. reactans, 
at least in vitro, produced a quantity of WLIP 
which is more than ten fold higher the 
quantity of tolaasin I produced by the type strain 
NCPPB2192 of P. tolaasii. The lower antifungal 
activity of WLIP appear to be compensated 
by the higher quantity produced in culture. 
Furthermore, the observation that morphological 
variants of P. reactans strains are avirulent 
and do not produce WLIP (Lo Cantore, 2001; 
Iacobellis and Lo Cantore, 2003) further 
support the possibility that the latter compound 
may play an important role in the interaction of 
P. reactans with the cultivated mushrooms 
(Lo Cantore et al. 2006).
Assay on tissue blocks and whole 
sporophores of Agaricus bisporus
Assays of the two LPDs on tissue blocks of 
A. bisporus showed that the deposition on their 
surface of a drop of solution containing 0.08 µg 
of tolaasin I caused brown sunken lesions. In the 
same assay condition a similar effect was observed 
when drops of solution containing 1.28 µg of 
WLIP were used (Fig. 6). Similar results were 
obtained when such LPDs have been deposited on 
the surface of whole sporophores caps (Lo Cantore 
et al. 2006).
Haemolytic activity and osmotic 
protection
Agarose haemolysis assay showed that both WLIP 
and tolaasin I cause the red blood cells (RBCs) 
lysis (Table 3). however, the minimal haemolytic 
quantity of tolaasin I, in the assay conditions, was 
more than four fold higher than that of WLIP and, 
moreover than, as previously reported (Rainey 
et al. 1991), it was temperature dependent. How-
ever, this effect was not observed in the case of 
WLIP. The higher temperatures might facilitate 
the formation of oligomers of tolaasin I leading 
to the transmembrane pore formation (Lo Cantore 
et al. 2006).
Assays in water solution conﬁ  rmed the higher 
haemolytic activity of WLIP. In fact, the minimal 
haemolytic concentration was 12.6 and 2.8 µM for 
tolaasin I and WLIP, respectively (Lo Cantore et al. 
2006). In similar assays, Rainey et al. (1991) 
reported that 0.25 µM solution of tolaasin I deter-
mined an haemolytic effect. However, the latter 
experiments were performed on horse erythrocytes 
at 37 °C and also with the purpose to measure the 
lysis rate.
In the solution assay, as shown in Figure 7, 
both tolaasin I and WLIP caused human RBCs 
lysis. WLIP was more effective than tolaasin I 
with regard to both C50 (i.e. the minimal 
concentration able to cause 50% haemolysis, 
which was close to 34.6 and 4.3 µg/ml for tolaa-
sin I and WLIP, respectively) and of the hae-
molysis rate (Fig. 7, inset). The Hill coefﬁ  cient 
associated to the formation of the active unit, 
appeared to be higher for WLIP (8 ± 2) than for 
tolaasin I (6 ± 1).
The haemolytic activity of both LDPs can be 
prevented by adding osmoticants of adequate 
dimensions to the external medium. The results 
reported in Figure 8 suggest for WLIP and tolaasin 
I, at a concentration corresponding to 1.5 × C50, a 
pore radius between 1.5 ± 0.1 and 1.7 ± 0.1, and 
2.1 ± 0.1 nm, respectively.
The small molecular size of the above LDPs 
suggests that such large pores could be formed 
by an aggregate of monomers, which is also 
consistent with the large Hill coefficients 
observed. The structure of the pore formed by 
AB
Figure 6. Brown lesions on tissue blocks of Agaricus bisporus (lower 
three blocks in each treatment), caused by deposition of 5 µl solutions 
containing 5.12 µg of WLIP (A) and 0.64 µg of tolaasin I (B), 
respectively. On upper blocks, 5 µl of sterile water was deposited.89
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WLIP appeared to be less stable with a more 
pronounced dependence on toxin concentration. 
In fact, at higher toxin dose (2 × C50) a bigger 
osmoticant is necessary for fully protect of RBCs 
from lysis (Fig. 8, right bottom panel) (Caraiola 
et al. 2006).
Theoretical analysis of the protection 
experiments with the Renkin equation permits an 
estimation of the functional pore radius which was 
1.1 ± 0.1 and 2.0 ± 0.4 nm, for WLIP and tolaasin 
I, respectively. These radius values are similar to 
those found for other LDPs (Dalla Serra et al. 
1999a). The previous smaller estimation of the 
functional pore radius of tolaasin I, reported by 
Rainey et al. (1991) to be 0.9 ÷ 1.0 nm, could 
depend on the lower tolaasin I concentration used 
in the experiments by the authors.
The Solution Structure of Tolaasin I
Secondary structure of tolaasin I
NMR spectra of tolaasin I were obtained in 
different solvents (
1H2O, C
2H3O
1H, DMSO-d6, 
and aqueous SDS). Assignment of proton spin 
systems in all solvents used was obtained with 
the sequential methodology (Wüthrich, 1986). 
Tolaasin I secondary structure was delineated 
from the qualitative pattern recognition approach 
of the sequential and medium-range NOEs as 
derived from 2D experiments. In 
1H2O and 
C
2H3O
1H, NOESY spectra essentially displayed 
sequential effects indicating that the conformation 
of the whole peptide was largely extended. In 
DMSO-d6, proton chemical shifts were found to 
correspond to those previously reported (Nutkins 
et al. 1991). NOESY spectra with 0.10 and 0.25 
second mixing times showed some short- and 
medium-range NOEs in the region DSer3-DLeu7 
in correspondence of tight turns as well as helical 
structure (Wagner et al. 1986). Most likely it was 
detected what is referred to as “nascent helix” 
(Dyson et al. 1988). The rest of the peptide proved 
to be essentially extended. The solution structure 
of tolaasin I was then studied in a 
1H2O/
2H2O 
(90/10 v/v) solution in presence of SDS at pH 7.0, 
a value at which the activity on erythrocytes is 
greatest (Raney et al. 1991). The amide region of 
the NOESY spectrum at 0.10 s mixing time is 
shown in Figure 9.
Table 3. Minimal haemolytic quantity (M.H.Q.) of tolaasin I or WLIP as determined in agarose plate assay at 
different temperatures.
Lipodepsipeptide  Average Diameter of the Haemolysis Area (mm)
quantity (µg)  Tolaasin I  WLIP
  25 °C  37 °C  25 °C  37 °C
10.24 8  16  24  24
5.12 7  11  22  22
2.56 7  7  18  18
1.28 0  0  11  11
0.64 0  0  9  9
0.32 0  0  0  0
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Figure 7. Dose dependence of the haemolytic activity of tolaasin I 
(circles) and WLIP (squares) after 4 hours at room temperature. 
Dotted lines are best ﬁ  t experimental data points with Hill equation. 
Hill coefﬁ  cients are 6.3 and 8.0 for tolaasin I and WLIP, respectively. 
Inset: Set of traces recorded on the microplate reader of kinetics of 
haemolysis of RBC exposed to 2 step sequential dilutions of tolaasin 
I (left) and WLIP (right), from top to bottom. Starting concentration 
(top panels) were 100 µg/ml for tolaasin I and 6.25 µg/ml for WLIP. 
The decrease of turbidity over time indicated the disappearance of 
intact RBC. All panels have the same linear axis, ranging from 0 to 
4 hours and from 0 to 110 mOD for x- and y-axes, respectively.90
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Sequential strong, non ambiguous cross-peaks 
between all consecutive amino acids, with the only 
exception of the DGln10-LLeu11, LIle15-LHse16, 
LHse16-DDab17 cross-peaks due to peak overlap 
were observed. Furthermore, several cross-peaks, 
namely DLeu4-DSer6, DVal8-DGln10, LLeu11-
∆But13, DVal12-DalloThr14 and LHse16-LLys18, 
were clearly observed. The presence of strong 
sequential NOEs together with medium in the 
region DPro2-LVal9 is a ﬁ  rst indication of a helical 
structure. This NOE pattern, generally observed 
for right-handed helical structures in peptides and 
proteins with L-aminoacids, suggests here the pres-
ence of a left-handed helix.
Observation of several medium-range effects 
suggests the presence of an ordered structure. 
However, it is important to underline that the stan-
dard distances observed for helices, β-sheets and 
turns in peptides and proteins containing only D- or 
L-residues cannot be used here to infer simply the 
folding of tolaasin in the region containing alter-
nate D- and L- amino acids. Not withstanding, the 
presence of key NOE effects between non-
sequential residues of the same chirality hints at a 
turn like folding. In order to clarify the issue, the 
NOESY cross-peak intensities expected for a 
regular left-handed helix covering the 2–14 region, 
including the DPro2-DVal8 and the alternating 
L- and D-amino acids were calculated (Jourdan 
et al. 2003).
Three-dimensional structure 
of tolaasin I
In SDS micelles, tolaasin I forms an amphipathic 
left-handed α-helix in the region DPro2-DThr14. 
It comprises a sequence of seven D-amino acids 
(DPro2-DSer-DLeu-DVal5-DSer-DLeu-DVal8) and 
a stretch of L-D-L-D-D-amino acid residues (LVal9-
DGln-LLeu-DVal-∆But-DalloThr14) (Jourdan et al. 
2003). A stereoview of the best ﬁ  t superposition of 
the backbone atoms of the 20 rSA/rEM structures 
is shown in Figure 10A.
This is the ﬁ  rst recognized example of a natu-
rally occurring molecule with a regular left-handed 
α-helix including both D- and L-amino acids, and 
it could be relevant for the de novo design of pro-
tein structure. As a comparison, the closely related 
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Figure 8. Haemolysis in the presence of osmotic protectants and 
Renkin ﬁ  t. Upper panels: Representative traces of decrease in 
turbidity of a RBC suspension in the presence of different external 
PEG osmolites and constant LDP concentrations (i.e. 100 µg/ml and 
6.25 µg/ml for tolaasin I and WLIP, respectively). PEG size is indicated 
next to each trace. Lower panels: Renkin representation of data 
collected in experiments similar to those reported in the upper panels. 
Curves through points are best ﬁ  ts according to Renkin equation [see 
text; Schultz and Solomon (1961); Ginsburg and Stein (1987)], which 
gives a pore radius for tolaasin I of 2.1 ± 0.1 nm. This value does not 
dependent on LDP concentration, at least at the concentrations used 
in this study (i.e. 50–100 µg/ml): dotted is the best ﬁ  t of data collected 
at [tolaasin I] = 76 µg/ml (triangles, 2 × C50), solid line refers to best 
ﬁ  t of data collected at [tolaasin I] = 50 (squares, 1.5 × C 50) and 
100 µg/ml (circles, 3 × C50). On the other hand, WLIP shows different 
values of pore radius, ranging from 1.5 to 1.7 nm depending on toxin 
concentration. Dotted line is the best fit of data collected at 
[WLIP] = 6.25 µg/ml (circles, 1.5 × C50), solid line refers to best ﬁ  t of 
data collected at [WLIP] = 9 µg/ml (squares, 2 × C50).
Figure 9. The amide region of NOESY spectrum of tolaasin I in 
1H2O/
2H2O (90/10 v/v) in the presence of SDS with a mixing time of 
0.10 s, 300 K, pH 7.0. Where space permits, the cross-peaks are 
labeled with the sequence number of amino acid residues.91
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lipodepsipeptide syringopeptin 25-A also forms a 
left-handed α-helix, but only includes residues of 
D-chirality (Ballio et al. 1995). A percentage of 
20% left-handed α-helix has been calculated from 
CD data, and it was hypothesized that the helix 
could be located in the N-terminal sequence of 7 
D-amino acids (Mortishire-Smith et al. 1991a). 
However, the CD data do not allow to speciﬁ  cally 
position the helix in the sequence as 20% of the 
sequence represents only 3.6 residues, i.e. a single 
helix turn.
The C-terminal lactone loop adopts a “boat-
like” conformation and is found shifted from the 
helical axis, therefore tolaasin I assumes a 
“golf-club” conformation (Fig. 10B) (Jourdan et al. 
2003). This “golf club-like” overall conformation 
seems likely to anchor in plasma membrane by 
means of its amphipatic helical segment with the 
hydrophobic lactone loop lying close to the surface. 
Further studies remain highly desirable to under-
stand how such a structure can create ion channels 
in plasma membranes. In particular, the formation 
of oligomeric structures, already hypothesized for 
syringomycin and syringopeptins, (Feigin et al. 
1997; Hutchison and Johnstone, 1993; Dalla Serra 
et al. 1999a; 1999b) is now under investigation for 
tolaasin I.
It has been reported that the cationic heptapeptide 
ring in polymixyns (Storm et al. 1977), ranalexin 
(Clark et al. 1994), and in type-I brevinins 
(Simmaco et al. 1994) is responsible for the 
disruption of bacterial membrane permeability 
and thus for antibiotic activity. The octapeptide 
lactone ring of syringopeptins shows two 
positively charged residues as in the above 
molecules (Ballio et al. 1995). Also in the 
pentapeptidic C-terminal lactone ring in tolaasin 
I two positively charged groups (dDab17 and 
lLys18) are present. These ﬁ  ndings imply that, 
independently from its size, the presence of 
positive charges into the loop together with the 
amphipathic helix, represent a fundamental 
membrane-permeabilizing motif (Oren and Shai, 
1998; Andreu and Rivas, 1998).
Structure-activity relationships 
of tolaasin I
It has been reported that tolaasin I is able to cause 
horse erythrocytes haemolysis as consequence of 
transmembrane pores formation in erythrocyte 
(Raney et al. 1991). Because of its small size this 
effect may be the result of the monomer aggregation 
across the membrane. Zn
2+ inactivates ion channel 
formation probably via chelation of ionizable 
groups in the membrane near the site of the pore 
formation (Brodey et al. 1991). Tolaasin I 
secondary structure suggests that the amphipathic 
N-terminal α-helix is deeply anchored into the 
membrane, leaving the hydrophilic lactone ring 
close to the surface of membrane. A longer 
anchored tail might both result in a higher afﬁ  nity 
to the membrane and a stronger disrupting effect. 
Moreover, the length of the N-terminal sequence 
might play a central role in the formation of stable 
Figure 10. Calculated structures of tolaasin I (A) MOLMOL stereoview 
of the best-ﬁ  t superposition of the 20 lowest energy rSA/rEMconfor-
mations of tolaasin. Backbone atoms of residues 2–14 were used 
for the best ﬁ  t. (B) Stickgolf-club” like tolaasin I conformation. Dotted 
lines indicate hydrogen bondsalong the left-handed α-helix. The 
helical axis inside the helix is also represented. The shaded area 
simulates the ellipsoid that covers most of the backbone atoms of 
the lactone ring, and its largest axisis also shown.92
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oligomeric structures required for ion channel 
formation. This may explain the loss of activity 
in ion channels formation observed in the case of 
tolaasin 144, an altered tolaasin I derivative 
lacking DSer6-DLeu7-DVal8. Preliminary MD 
simulations indicate that the N-terminal sequence 
of tolaasin 144 is more ﬂ  exible than tolaasin I and 
it does not fold into a stable α helix. These feature 
may prevent the oligomeric aggregate formation 
and may explain the fact that tolaasin I lyses 
erythrocytes by two mechanisms (Hutchison and 
Johnstone, 1993). At low tolaasin I concentration 
the activity is the result of Zn
2+-sensitive ion 
channel formation whereas at high concentrations 
it is the result of Zn
2+-insensitive detergent action 
of both molecules. It has been reported that the 
α-helical structure, while important for cytotoxicity 
toward mammalian cells, is not a prerequisite for 
antibacterial activity (Shai and Oren, 1996). Novel 
antibiotic peptides useful as therapeutic drugs 
require strong antibiotic activity against bacterial 
and fungal cells without haemolytic effect (Raney 
et al. 1991). Functional and structural studies with 
D-amino acids incorporated analogues of pardaxin 
reveal that the lack of a signiﬁ  cant α-helix does 
not prevent the lysis of bacterial membrane. The 
peptide is probably acting as a detergent in what 
has been described as a “carpet”-like mechanism 
(Shai, 1995; Shai and Oren, 1996). Therefore, the 
decrease of the helical content into lytyc peptides 
by incorporating D-amino acids may be a useful 
approach to discover new peptide antibiotics for 
therapeutic use. In this context, tolaasin I and 
tolaasin 144 are very interesting molecules: the 
presence of a stable α-helix in the former warrants 
its lytyc activity, while the decreased helical 
content together with the detergent action exerted 
by tolaasin 144 strongly suggest its possible role 
as antibacterial, but not cytotoxic, peptide. 
Furthermore, the above substances present L-
amino acids into a D-amino acid sequence: this 
induces resistance to enzymatic degradation and 
inactivation (Wade et al. 1990), and increase 
antigenicity (Benkirane et  al. 1993). The 
antimicrobial assays of tolaasin I, though limited 
to a representative set of test micro-organisms, 
conﬁ  rmed the high sensitivity of Gram-positive 
bacteria, as previously reported (Raney et al. 
1991), and showed a quite good activity toward 
the yeast Rhodotorula pilimanae and the Gram 
negative bacterium E. coli (Lo Cantore et al. 
2003a; 2006). The activity against E. coli (strain 
ITM100), in contrast with the results previously 
reported (Raney et al. 1991), indicates a variability 
of sensitivity among strains, and strongly suggests 
that before conclusions are drawn several strains 
of the same micro-organisms must be checked. It 
would be of interest to test tolaasin I and tolaasin 
144 against Gram-positive and Gram-negative 
bacteria of medical interest. Finally, the structural 
information on tolaasin I can be extremely helpful 
for its possible use in the control of the brown 
blotch disease of A. bisporus also in combination 
with other methods. Treatment of mushrooms caps 
with tolaasin I provokes pitting and browning 
(Raney et al. 1991) as well as activation of the 
defense mechanism of the mushroom (Soler-Rivas 
et al. 1999a). Nutkins et al. (1991) reported that 
partially purified toxin reproduces disease 
symptoms, as does the intact organism, although 
tolaasin I induces more prominent symptoms than 
living bacteria (Moquet et al. 1996). Accordingly, 
tolaasin I appears to be an adequate target to stop 
the sequence of events affecting A. bisporus. The 
fact that WLIP appears to be able to inhibit the 
browning could conﬁ  rm this hypothesis (Jourdan 
et al. 2003).
Isolation and Chemical 
and Biological Chracterization 
of News Tolaasins
Tolaasins A-E (11–15, Fig. 11), were isolated 
together with tolaasins I and II from the cell-free 
culture ﬁ  ltrate of the type strain NCPPB2192 of 
P. tolaasii essentially by semi-preparative HPLC 
as above cited (Fig. 4).
A preliminary analysis of 
1H NMR and ESIMS 
data of these metabolites indicated that the new 
lipodepsipetides are structurally related to tolaa-
sins I (8) and II (10) as previously suggested by 
Shirata et al. (1995). The authors isolated eight 
tolaasins, including tolaasins I and II from 
P. tolaasii cultures ﬁ  ltrates and hypothesized, only 
on the basis of MS data, that their structural fea-
tures were similar to 8 and 10. In our case seven 
tolaasins, including tolaasins I and II, were iso-
lated and the structures of two of them differ from 
those hypothesized from Shirata et al. (1995). A 
complete NMR-based structural elucidation of 
tolaasins A-E (11–15) was not an easy task to 
accomplish, due to the low amount of substances 
available. For this reason, while a full character-
ization of the 
1H-NMR spin systems was achieved 93
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through extensive use of 2D NMR techniques, 
13C NMR carbon chemical shifts could not be 
assigned. Attempts to aquire 
13C NMR data by 
means of suitable 2D NMR experiments (HSQC 
and HMBC) at very long-acquisition time failed. 
The assignment of the proton spin systems of each 
amino acid residue, including the identiﬁ  cation of 
the N-terminal side chain, was mainly obtained 
from the 2D TOCSY and the 2Q (Double quantum 
spectroscopy) experiments (Wüthrich, 1986; p 
292). The 2Q spectrum was acquired in order to 
assess the sequence speciﬁ  c assignment of the spin 
systems preliminarily characterized in the TOCSY 
spectrum, together with the pattern analysis of 
sequential dipolar couplings displayed in the 2D 
NOESY spectrum (Wüthrich, 1986; p-292). Full 
proton assignments for tolaasins A-E (11–15), in 
DMSO-d6 at 300 K were obtained (Bassarello 
et al. 2004).
Tolaasin A (11) showed a pseudomolecular ion 
peak in the HRESIMS spectrum at m/z 980.0912 
(M+2H)
2+, consistent with the molecular formula 
C91H155N21O26 (exact mass calculated for 
C91H157N21O26/2 980.080435). HRESIMS data were 
obtained also for the intense fragment ion (M-φchain-
∆But1+H) and interpreted as originating from the 
elimination of [HOOC-(CH2)3CONHC=CH(CH2)-
C=O] with hydrogen transfer to the charged 
species (see below). Extensive analysis of the 
1H NMR data of tolaasin A (11), including TOCSY, 
DQF COSY, and 2Q spectra, permitted conﬁ  rmation 
of the same amino acid sequence present in 
the parent tolaasin I (8). Moreover, the Thr14 
residue and the C-terminal Lys18 were found to 
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Figure 11. Structures of tolaasins II and A-E (10–15).94
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be involved in the lactone formation, as already 
observed for tolaasin I. On the other hand, a dif-
ferent nature of the N-terminus φ chain was sug-
gested by the analysis of the DQF-COSY spectrum. 
The N-terminus blocking group was unequivocally 
identiﬁ  ed by the fragmentation peaks observed in 
the ESIMS spectrum and appeared to have a 
HOOC-(CH2)3-CO- structure. Finally, the ESI 
MS/MS (collision induced dissociation) spectrum, 
conﬁ  rmed the same amino acid sequence for the 
two depsipeptides.
Tolaasin B (12) showed a pseudomolecular ion 
peak at m/z 1973 (M+H)
+, 14 Daltons less than 
tolaasin I, suggesting that tolaasin B could differ 
from the analog tolaasin I by the absence of a 
methylene group. NMR and the ESIMS data per-
mitted to deduce for tolaasin B a molecular for-
mula C93H161N21O25. Moreover, several peptide 
fragmentation peaks generated by a stepwise 
spontaneous loss of amino acid residues from the 
N-terminus were observed. The TOCSY spectrum, 
almost superimposible to that of tolaasin I, permit-
ted the identiﬁ  cation of tolaasin B (12), which 
shows the substitution of the isoleucine spin sys-
tem present in tolaasin I (8) with a proton con-
nectivity consistent with a valine residue. Two 
intense NOE correlations were observed between 
Hse16 NH and Val Hα, and Val NH and Thr14 
Hα, conﬁ  rming that the valine residue is at posi-
tion 15. The presence of the intact lactone moiety 
was conﬁ  rmed by CID MS/MS analysis. Taken 
together the above data allowed to establish the 
structure 12 for tolaasin B.
Tolaasin C (15) showed a pseudomolecular ion 
peak at m/z 2005 (M+H)
+ corresponding to a 
molecular weight of 2003 Da, 18 mass units greater 
than that of tolaasin I, suggesting that tolaasin C 
may be the acyclic version of tolaasin I derived by 
the hydrolysis of its lactone ring (molecular for-
mula C94H165N21O26). Comparison of 2D NMR 
spectra and the ESIMS fragmentation patterns of 
tolaasins C (15) and I (8) further supported the 
hypothesis that tolaasin C is a linear peptide gener-
ated from the hydrolysis of the lactone ring. In fact, 
the proton chemical shifts of the dehydroamino-
butyric acid residue at position-13 (∆But13) and 
the threonine at position-14 suggested that the 
hydroxyl group of the side chain of this residue is 
not involved in an ester functionality.
Tolaasin D (13) exihibited a pseudomolecular 
ion peak at m/z 1987 (M+H)
+, suggesting the same 
molecular formula C94H163N21O25 already observed 
for tolaasin I. Thus tolaasin D (13) and I (8) are 
isomers. A careful comparison of the TOCSY 
spectra of tolaasin D and I indicated that tolaasin 
D contained a leucine residue in place of the iso-
leucine present in the related lipodepsipeptide 8. 
The 2Q spectrum allowed to speciﬁ  cally assign the 
resonances of the leucine methylene protons. The 
position 15 of the leucine was supported by two 
NOE effects between Hse16 NH and Leu15 Hα, 
and between Leu15 NH and Thr14 H α.
Tolaasin E (14) showed a pseudomolecular ion 
peak at m/z 1943 (M+H)
+ suggesting the same 
molecular formula C92H159N21O24 of tolaasin II 
(10). Hence, tolaasin E (14) is isomeric with tolaa-
sin II (10). The latter depsipeptide, contains a 
glycine residue in place of the homoserine residue 
of tolaasin I (8). In fact, in the TOCSY spectrum 
of tolaasin E it was possible to characterize the 
spin system of a glycine residue, conﬁ  rming that 
14 is indeed a tolaasin II analogue. The 2Q exper-
iment indicated the presence of four rather than 
three leucine residues. A careful examination of 
the NOESY and TOCSY spectra conﬁ  rmed that 
the ﬁ  rst three leucine residues are at positions 4, 7 
and 11, as in tolaasin II (10). NOE correlations 
allowed the placement of the fourth leucine at 
position 15 in tolaasin II. A support to the struc-
ture of tolaasin E was the presence of the β-
hydroxyoctanoil φ chain at the N-terminus as 
deduced by ESIMS data through the spontaneous 
loss of 225 Da (the φ chain + ∆But1) from the 
pseudomolecular ion peak at m/z 1943.
The antimicrobial activity of HPLC grade tolaa-
sins A-E (11–15)—assayed in comparison with 
tolaasin I and II against the yeast R. pilimanae, the 
fungus Rizoctonia solani, the Gram-positive 
bacteria B. megaterium and Rodococcus fascians, 
respectively, and the Gram-negative bacteria 
E. coli and Erwinia carotovora subsp. carotov-
ora—is reported in Table 4. B. megaterium and R. 
fascians were the most sensible test micro-organ-
isms. In fact, all the analogs, except tolaasin C, 
inhibited the growth of these bacteria though dif-
ferences among their specific activities were 
observed. The most active analogs appear to be 
tolaasin D followed by tolaasin I and II with a 
minimal inhibitory quantity of 0.16, 0.32 and 0.64 
µg, respectively. Tolaasins A and B, and E were 
less active, with a minimal inhibitory quantity of 
1.28 and 2.56 µg, respectively. A similar sensitiv-
ity to the above substances was shown by the 
fungus R. solani. None of the analogs inhibited the 95
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growth of the Gram-negative bacteria E. coli and 
E. carotovora subsp. carotovora at least at the 
concentration used in the assays. Finally, the 
growth of the yeast R. pilimanae was inhibited only 
by tolaasins I, II, A and D though the sensitivity of 
the yeast was lower in comparison to B. megate-
rium (Table 4). The results of the antimicrobial 
activity of the tolaasins suggest the importance in 
this respect of the lactone and the N-terminus acyl 
moiety. Tolaasin A, which has the pentadioic acid 
instead of the β-hydroxyoctanoic acid, showed a 
reduced activity in respect to tolaasin I while tolaa-
sin C, the linear derivative of tolaasin I, due to the 
lactone opening, lacked the activity at least at the 
concentration tested. The effect of the lactone ring 
opening on the lack of the antimicrobial activity 
has been already reported for other bacterial 
lipodepsipeptides (Jourdan et al. 2003). Further-
more, the importance of the position 15 in the 
peptide moiety of both tolaasins I and its deriva-
tives in respect to the antimicrobial activity was 
observed. In fact, the replacement of isoleucine in 
position 15 with a valine or leucine residue in 
tolaasins B and D, respectively, determines the 
decrease or the increase of the antimicrobial activ-
ity when compared to tolaasin I. The presence of 
leucine in position 15 in tolaasin E determined the 
reduction of the activity when compared to tolaa-
sin II. Though the latter result is apparently in 
contrast with the effect of the same replacement in 
the tolaasin D, it is important to consider that 
tolaasin II differ from tolaasin I for the replacement 
of the homoserine in position 16 with a glycine 
residue (Bassarello et al. 2004).
As previously reported tolaasin I forms an 
amphipatic left-handed α-helix in the region 
DProd2-DalloThr14 comprising the sequence of 
seven D-amino acids and the adjacent L-D-L-D-
D-region. Furthermore, the lactone macrocycle 
adopts a “boat-like” conformation and is shifted 
from the helical axis giving rise to a “golf-club” 
overall conformation. These structural features 
appear of importance on toxicity of tolaasin I 
(Jourdan et al. 2003). Therefore, structural changes, 
occurring in position 15 in the case of tolaasins B 
and D, in position 16 in tolaasin II, and in both 
position 15 and 16 in tolaasin E, may modify this 
lactone conformation and consequently the 
antimicrobial activity (Bassarello et al. 2004).
Mode of Action of Tolaasin I 
and WLIP on Natural and Model 
Membranes
The activity WLIP and tolaasin I was compara-
tively evaluated on lipid membranes. Both LDPs 
induced the release of calcein from large unilamel-
lar vesicles (LUVs). Their activity was dependent 
on the toxin concentration and liposome composi-
tion and in particular it increased with the sphin-
gomyelin (SM) content of the membrane. Studies 
of dynamic light scattering suggested a detergent-
like activity for WLIP at high concentration (27 
µM). This effect was not detected for tolaasin I at 
the concentrations tested (28 µM). Differences 
were also observed in LDPs secondary structure. 
In particular, the conformation of the smaller WLIP 
changed slightly when it passed from the buffer 
solution to the lipid environment. On the contrary,  
a valuable increment in the helical content of 
tolaasin I, which was inserted in the membrane 
core and oriented parallel to the lipid acyl chains,   
was observed. The novelty of the pathogenetic 
capability of P. reactans and, in particular, the fact 
that avirulent variants of the pathogen have also 
lost the ability to produce WLIP (Lo Cantore and 
Iacobellis, 2002) suggest that this metabolite may 
be important in the P. reactans-mushrooms 
Table 4. Antimicrobial activity of tolaasins I, II, and A-E.
Micro-organism  Tolaasins Minimal Inhibitory Quantity (µg)
 I   II  A B C D E
Rizoctonia solani  1583  0.32 0.64 1.28 2.56 5.12 0.16 5.12
Rhodotorula pilimanae ATCC26423  2.56  5.12  5.12   5.12   5.12  2.56  5.12
Bacillus megaterium  ITM100  0.32 0.64 1.28 2.56  5.12 0.16  2.56
Rodococcus fascians  NCPPB3067  0.32 0.64 1.28 1.28   5.12  0.16  2.56
Escherichia coli K12 ITM103  5.12  5.12  5.12  5.12  5.12  5.12   5.12
Erwinia carotovora subsp.   5.12  5.12  5.12  5.12  5.12  5.12   5.12
carotovora ICMP570296
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interactions. Although the haemolytic and the 
antimicrobial activity of WLIP and its interactions 
with synthetic membranes have been recently 
demonstrated (Lo Cantore et al. 2003a, p 255–62; 
Lo Cantore et al. 2003b, p 263–73; Lo Cantore 
et al. 2006), the mechanism involved is not yet 
deﬁ  ned. The effects of WLIP on model membranes 
of different lipid composition, also in comparison 
to tolaasin I, were investigated analysing the LDPs 
mode of action and the molecularity of the per-
meabilising unit. In addition, the changes in the 
secondary structure occurring when these mole-
cules passed from the aqueous buffer to the mem-
brane were studied. In particular, it was possible 
to analyse the conformation of WLIP and tolaasin 
I during their interaction with the lipid membrane, 
i.e. their natural target, and, in the case of tolaasin I, 
to calculate the molecule orientation with respect 
to the lipid acyl chains (Coraiola et al. 2006).
Calcein release assay
Both WLIP and tolaasin I are able to damage bio-
logical and artiﬁ  cial membranes through the forma-
tion of transmembrane pores (Brodey et al. 1991; 
Cho and Kim, 2003; Lo Cantore et al. 2003b, p 
263–73; Lo Cantore et al. 2006).
Tolaasin I was more active on SM- and 
phospholipids containing LUVs and less active 
when sterols were present (Table 5 and Fig. 12). 
This feature, observed for other peptin-like LDPs 
(Dalla Serra et al. 1999b; Menestrina, 2003, 
p 185–98), was correlated to their cell speciﬁ  city 
being peptin-like LDPs more phytotoxic and less 
antifungal than the smaller LDPs such as the 
nonapeptides syringomycines, pseudomycines and 
cormycin. The latter showed a clear preference for 
sterols (Bender et al. 1999; Dalla Serra et al. 1999b; 
Menestrina 2003; Julmanop et al. 1993; Taguchi 
et al. 1994; Feigin et al. 1997; Scaloni et al. 2004). 
In the case of tolaasin I, the slight preference for 
ergosterol (a fungal sterol) among sterols is 
consistent with its antifungal activity.
On the contrary to the expectations, also WLIP, 
which is a nonapeptide, was more active on SM-
containing LUVs. This could be explained by the 
fact that this LDP shows structure similarity 
with the peptine-like LDPs with only a portion of 
the peptide moiety involved in the formation of 
the lactone ring. In comparison to tolaasin I, the 
inhibitory effect of sterols was less effective on the 
WLIP activity.
Nevertheless the two toxins showed similar 
responses to changes of the lipid membrane com-
position.
Firstly, the molecularity of the permeabilising 
unit, estimated from the Parente-Rapaport model 
and reported in Table 5, was larger with WLIP and 
in the same range of detergents (Dalla Serra et al. 
1999a). In the case of tolaasin I, Cho and Kim 
(2003) described the existence of subconductance 
states, which could be related to the presence of 
pores with slightly different molecularities. 
Table 5. Permeabilizing activity of WLIP and tolaasin I on vesicles of different lipid composition and a statistical 
analysis of their pore-formation mechanism.
Lipid Composition
a
(mol%) WLIP  Tolaasin  I
PC SM sterol  1/C
b
  50 (µM
-1) K1
  c (M
-1) M
d K 2
  e 1/C
b
  50 (µM
-1) K1
  c (M
-1) M
d K 2
  e
100 0  0  0.59  ± 0.04  50 ± 20  8 ± 1  533 ± 451  2.8 ± 0.4  233 ± 52  6 ± 1  5.2 ± 2.6
50 50  0  1.41  ± 0.05  100 ± 30  6 ± 1  200 ± 340  4.9 ± 0.2  673 ± 179  6 ± 1  1.7 ± 1.1
50 33  16.5* 0.70  ± 0.05  100 ± 30  12 ± 1  217 ± 247  2.8 ± 0.2  200 ± 50  6 ± 1  12 ± 12
50 16.5 33*  0.59  ± 0.01  50 ± 20  8 ± 1  533 ± 451  1.2 ± 0.2  100 ± 30  7 ± 1  19.7 ± 17.4
50 0 50*  0.45  ± 0.01  50 ± 20  11 ± 1  533 ± 451  0.4 ± 0.1  50 ± 20  7 ± 1  0.8 ± 0.3
50 33  16.5
§ 0.70  ± 0.03  100 ± 30  12 ± 1  413 ± 440  2.5 ± 0.2  250 ± 54  7 ± 1  2.8 ± 1.7
50 16.5 33
§ 0.59  ± 0.08  50 ± 20  8 ± 1  533 ± 451  1.3 ± 0.1  100 ± 30  7 ± 1  30 ± 20
50 0 50
§ 0.54  ± 0.01  50 ± 20  10 ± 1  533 ± 451  1.0 ± 0.2  50 ± 20  5 ± 1  30 ± 20
aLipid mixtures are reported on a molar base. PC: egg phosphatidylcholine; SM: sphyngomyelin; the sterol included in the vesicles was 
cholesterol* and ergosterol
§.
bThe permeabilising activity is expressed as the reciprocal of the concentration of toxin causing 50% of calcein release (C50). Data are 
average ± S.D. of at least two different experiments.
cThe partition coefﬁ  cient of toxin monomers into the liposome.
dThe number of monomers necessary for the formation of an active pore.
eThe aggregation process of membrane-inserted monomers.
c; 
d ; 
eData are average ± S.D. of at least three different experiments.97
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This instability of the pore structure well correlates 
with the variability of the parameter M found by 
our analysis (Coraiola et al. 2006).
For both of LDPs the activity seemed mainly 
due to the ability of monomers to bind to the 
liposome membrane (K1) rather than to the two-
dimensional aggregation rate (K2) of the bound 
peptide (Caraiola et al. 2006).
Dynamic light scattering
From the results reported in Figure 13 it was 
evident that WLIP solution at concentration higher 
than 27 µM showed a detergent-like activity; in 
fact, the intensity of the scattered light lowered 
probably in consequence of vesicles micellization. 
On the contrary, both LDPs at low concentration 
(at a LDP to lipid molar ratio up to 0.3) caused an 
increase of the liposome dimensions and a decrease 
of the intensity of the diffused light. These effects 
well correlated with vesicles aggregation, that 
increased the measured diameters, and with pre-
cipitation of vesicle macro-aggregates which 
caused a decrease of signal intensity through a 
decrease of the concentration of scattering cen-
tres.
Interestingly, the concentrations of WLIP and 
tolaasin I used in these assays were of the same order 
of magnitude required to induce mushroom tissue 
alteration in vivo (Lo Cantore et al. 2006; Brodey 
et al. 1991; Hutchison and Johnstone, 1993). Also 
the different activity between the two LDPs was 
observed, being WLIP about ten times less active 
than tolaasin I (Lo Cantore et al. 2003a; 2006).
Fourier-transformed infrared 
spectroscopy experiments
The results reported in above paragraphs together 
with those in Lo Cantore et al. (2006), supported 
the idea of the cell membrane as the main target 
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Figure 12. Dose dependence activity of tolaasin I on liposomes with 
different lipid composition: Calcein loaded liposomes were exposed 
to different peptide concentrations. The percentage of calcein release 
was determined after 45 min as a function of the toxin/lipid ratio (T/L) 
and expressed as % of the maximal value obtained with TritonX-100. 
Experiments were done at constant lipid concentration (about 9 µM). 
The true toxin concentration used was reported in the upper scale 
of the panel. Lines through the points are best ﬁ  t according to the 
statistical model described in the text. Best values of ﬁ  tting parameters 
are reported in Table 1. Vesicles were prepared with the following 
compositions expressed in molar ratio: (down triangle) PC:SM 
(50:50), (up triangle) PC:SM:Chol (50:33:16.5), (circle) PC:SM:Chol 
(50:16.5:33), (square) PC:Chol (50:50).
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Figure 13. Effect of toxins on vesicle size as determined by dynamic 
light scattering: The treatment of phosphatidylcholine vesicle with 
tolaasin I (open square) and WLIP (close circle) caused changes in 
vesicle average size (∆ diameter) which was reported vs the toxin 
concentration (T), normalized to the vesicle diameter in the absence 
of toxin. Experiments were obtained at constant lipid concentration 
(80 µM). The toxin/lipid ratio (T/L) was reported in the upper scale of 
the same panel. Inset. In this case we analyzed the variation of the 
scattered light intensity (∆ ILS), normalized to the intensity value in 
the absence of toxin. Other parameters are as above.98
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for both WLIP and tolaasin I. Therefore it seemed 
of interest to investigate the conformational 
changes occurring when these molecules interact 
with the lipid environment. The secondary struc-
ture of both LDPs was already reported but only 
in the soluble form (Mortishire-Smith et al. 1991b; 
Jourdan et al. 2003). In particular, the conformation 
of tolaasin I was studied in SDS (Mortishire-Smith 
et al. 1991a, 1991b; Jourdan et al. 2003): in this 
membrane-like environment it was demonstrated 
the presence of a left-handed α-helix, suggesting 
a refolding of the structure from the aqueous buf-
fer where the conformation of the whole peptide 
was largely extended (Jourdan et al. 2003). Con-
sidering these results, FTIR spectroscopy was used 
to determine the LPDs conformation and to follow 
its changes when the molecules passed from hydro-
philic to a membrane mimetic environment. For 
this reason, FTIR spectra were collected in buffer 
solution, in an organic solvent (TFE, HFIP), in 
SDS or in the presence of lipid vescicles. The 
structure of peptides was analyzed in the lipid-
mimetic conditions provided by TFE, HFIP and 
SDS, as well as in the model lipid membrane of 
palmitolyl-oleoyl-phosphatidylcholine (POPC) 
liposome. Changes in the secondary structure of 
peptides passing from the water buffer solution to 
the more hydrophobic environment with a maxi-
mum effect in the presence of the lipid membrane 
were expected (Table 6).
The rigidity of WLIP, cyclized via lactone 
formation between the third and the C-terminal 
residues (Mortishire-Smith et al. 1991b), could 
explain the slight variation observed in the amide I’ 
spectrum even after the interaction with the membrane. 
Moreover, the presence in the same molecule of 
unusual residues made the assignment of a secondary 
structure to the curve fitting components more 
difﬁ  cult. Therefore the differential spectra obtained 
after H/D exchange or after the buffer substitution 
with a membrane-like environment were focused 
(Fig. 14). In fact, variations of spectra after H/D 
exchange provided information about the local 
structure of the molecule. The decrease of absorption 
at 1670 cm
−1 (and the corresponding increment at 
1634 cm
−1), for example, indicated the presence of 
free protons (i.e. not involved in hydrogen bonds) 
which were able to exchange with deuterium, probably 
because of their good accessibility allowed by the local 
structure of the molecule. This behaviour could be 
attributed to a turn conﬁ  guration with fast exchanging 
protons. Interestingly, this behaviour was dependent 
on the solvent used and decreased in a lipid-mimetic 
environment (effect measured by the small negative 
and positive peaks at 1670 cm
−1 and 1634 cm
−1, 
respectively), suggesting a decrease of the proton 
accessibility and, consequently, a change in the local 
structure of the molecule (Fig. 15A). Therefore, it 
seemed that the lipid-mimetic conditions enhanced 
the formation of hydrogen bonds inside the structure 
which become less susceptible to deuteration. Similar 
changes were confirmed in differential spectra 
Table 6. FTIR spectroscopy determination of the sec-
ondary structure of tolaasin I in aqueous buffer, with 
and without lipids, and in different solvents.
 %  Secondary  structure
a
System  β h r
buffer 29  44  27
TFE 24  45  30
HFIP 24  48  28
SDS 27  47  26
POPC 21  63  15
aβ: total β-structure (i.e. β-sheet, β-turn); h: helix; r: random. Errors 
of FTIR determinations are ±5%.
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Figure 14. Differential spectra after H/D exchange of the WLIP amide 
protons: Analysis of differences in the amide I band of ﬁ  lms of WLIP 
samples deposited from a buffer solution (B, dashed line), TFE (T, 
dotted line), HFIP (H, solid line), SDS (S, thick dashed line) and after 
binding to the lipid membrane (L, thick dotted-dashed line). Differen-
tial spectra were obtained by subtracting the hydrogenated spectra 
of WLIP in the different environments from the corresponding deuter-
ated spectra. (Inset) Area of negative peaks between 1710 and 1660 
cm
−1. All the differences are between normalized spectra, i.e. with 
the amide I’ peak area set at 1.99
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obtained by subtracting the deuterated spectrum of 
the soluble form in buffer from those obtained with 
other solvents (Fig. 15B). Variations in the absorption 
at the above wavenumbers showed an increment at 
1670 cm
−1 and a corresponding decrease at 1634 cm
−1 
with the maximum in the lipid membrane. These 
changes favoured a more stable local structure which 
was enhanced from the lipid-mimetic environments 
and that could be able to interact with the membrane 
and its hydrophobic moiety. In addition, the disordering 
effect on the vesicles membrane induced by the WLIP 
binding supports the hypothesis of an insertion of the 
molecule into the membrane lipid core.
As expected an increment of the helical content 
in the structure of tolaasin I was observed when it 
passed from the water buffer solution to the 
membrane-like environment. This is consistent 
with results obtained by CD and NMR spectroscopy 
in aqueous solution and in SDS, respectively 
(Mortishire-Smith et al. 1991a; Jourdan et al. 
2003). Nevertheless some considerations need to 
be added. The peptide moiety of tolaasin I (18 
aminoacids) includes unusual residues with 
D-chirality, so the standard assignment of second-
ary structures to the curve ﬁ  t components could be 
not always applied. Interesting recent studies were 
recently reported on α-helical membrane lytic 
peptides, in which a few L-amino acids were 
replaced with their D-enantiomers: incremented 
amide I’ frequencies (1656–1670 cm
−1) compared 
with pure α-helical structures (1645–1654 cm
−1) 
were observed and assigned to 310-helix or 
dynamic/distorted α-helix (Papo and Shai, 2004). 
Previous studies had correlated this region with 
310-helix (Kennedy et al. 1991), β-turn (Susi and 
Byler, 1986) and interestingly to a left-handed 
α-helix, as well (Giancotti et al. 1973; Citra and 
Alxelsen, 1996). In this analysis two components 
around the typical region of helix absorption, centred 
at 1654 cm
−1 and 1664 cm
−1, respectively (data not 
shown) were found (Fig. 16A and Table 7). After 
deuteration the position of both peaks did not 
change, suggesting a stable structure maintained 
by hydrogen bonds, like a helix. Moreover, the sum 
of percentage absorption of these two components 
kept at a constant value, independently of the 
environment (i.e. buffer, solvents and membranes), 
on the contrary the single absorptions changed: the 
peak at 1654 cm
−1 increased passing from buffer 
to solvents at expenses of peaks at 1664 cm
−1. After 
interaction with the membrane, the contribution of 
the former was maximum but analysis of the 
dichroic spectrum showed only one peak at higher 
wavenumber (1659 cm
−1) (Fig. 16B). For all these 
reasons, the two contributions were joined in an 
unique peak and assignto it a helix structure which 
ﬁ  nally resulted the conformation adopted from 
tolaasin I to bind the membrane and to insert in it. 
The signiﬁ  cant decrease in the orientation order 
parameter of the aliphatic chain region (Table 6) 
and the orientation of tolaasin I in the lipid bilayer 
prompt to interpret these results in favour of a 
barrel-stave mechanism of action versus a carpet 
like hypothesis (Malev et al. 2002). This is indeed 
in agreement with Bassarello et al. (2004) who 
described for tolaasin I the formation of a stable 
amphipathic helical structure and suggested its 
insertion into the lipid matrix for the formation of 
an ionic channel.
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Figure 15. FTIR-ATR spectra of WLIP in buffer and in lipid mimetic 
environments: (A) Analysis of the amide I’ band of deuterated ﬁ  lms 
of WLIP samples deposited from a buffer solution (buffer, thick dotted 
line) or after binding to the lipid membrane (POPC, solid line). The 
original spectrum (POPC) was deconvoluted and curve ﬁ  tted to 
resolve the component frequencies. The corresponding Gaussian 
bands are reported as dotted lines, and their sum as a thick dashed 
line superimposed to the original spectrum. (B) Differential spectra 
were obtained by subtracting the deuterated spectrum of the soluble 
form in buffer from that in TFE (1), in HFIP (3), in SDS (2) or in pres-
ence of the lipid phase (4).100
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On the contrary, a carpet-like mechanism was 
previously proposed for magainin derived lipopep-
tides which localized on the membrane surface and 
did not signiﬁ  cantly destabilise the acyl-chain order. 
In fact, Avrahami and Shai (2002) observed nega-
tive order parmeters for both natural magainin and 
lipo-magainin (magainin analogues conjugated 
with lipophilic acids), typical of helices oriented 
nearly parallel to the membrane surface. In addition, 
after incorporation of the peptides into the lipid 
membrane, the lipid order was only poorly dis-
turbed and to the same extent, suggesting that both 
peptides did not insert deeply into the lipid core.
A different mechanism of action could be 
proposed for WLIP, in agreement with the 
evidences here reported for membrane disruption 
in a detergent-like manner. In fact, it does not have 
a sufﬁ  cient length to transverse the entire membrane, 
similarly to syringomicin for which Malev et al. 
(2002) hypothesized a toroidal pore.
In conclusion, the results described shed light 
on the permabilising effects induced by WLIP and 
tolaasin I on liposome and on the secondary struc-
ture of these molecules during their interaction 
with the lipid membrane, which is their biological 
target (Caraiola et al. 2006).
Exo- and Lipo-Polysaccharide 
from Pseudomonas tolaasii, 
P. reactans and Burkholderia 
gladioli pv. agaricicola
In the last decades the chemical composition and 
structures of exopolysaccharides (EPSs), complex 
molecules of the bacterial capsules, of several plant 
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Figure 16. Analysis of FTIR-ATR spectra of tolaasin I in POPC layers 
with polarizer: (A) Spectra were taken with either parallel (0°) or per-
pendicular (90°) polarization. The amide I’ region of tolaasin I bound 
to vesicles was reported after subtraction of the lipid contribution. The 
best ﬁ  t curve with Gaussian components (dotted lines) was superim-
posed as a thick dashed line to the 90° polarized trace (solid line). The 
absorption bands in the parallel and perpendicular conﬁ  guration were 
used to calculate the orientation of the corresponding structural element 
as reported in Table 7. Bands are: h (helix), β (β-structure), r (random). 
(B) Dichroic spectrum obtained by subtracting the 90° polarized spec-
trum (after multiplication by Riso i.e. 1.54) from that at 0°.
Table 7. Assignment and dichroic ratio of some IR bands observed in lipid vesicles with and without toxin.
Wavenumber (cm
−1) Vibration
a Direction  (θ )
b Dichroic  Ratio Angle  (γ⊥)
c
Lipid alone      
2920 as  CH2 stretching  90°  1.32 ± 0.01  33° ± 1°
2850 s  CH2 stretching  90°  1.34 ± 0.01  34° ± 1°
LUVs + WLIP   
2920 as  CH2 stretching  90°  1.48 ± 0.01  41° ± 1°
2850 s  CH2 stretching  90°  1.52 ± 0.01  42° ± 1°
LUVs + tolaasin I    
2920 as  CH2 stretching  90°  1.61 ± 0.01  45° ± 1°
2850 s  CH2 stretching  90°  1.63 ± 0.01  45° ± 1°
1660  Amide I’ helix  30°  2.51 ± 0.10  47° ± 2°
aas: asymmetric; s: symmetric.
bDirection of the variation of the dipole moment associated to the vibration with respect to the direction of the main molecular axis 
(aliphatic chain or α-helix axis).
cAverage angle between the direction of the molecular axis and the perpendicular to the crystal plane (i.e. membrane plane).101
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pathogenic bacteria have been determined. Some 
EPSs have a very complex structure, being hetero-
geneous branched heteropolymers. The differences 
in the chemical composition and structures of the 
EPSs puriﬁ  ed from different plant pathogens sug-
gest that these molecules may play speciﬁ  c and 
different roles in plant-pathogen interaction 
(Evidente and Motta, 2002, p 581–629).
The involvement of extracellular polysac-
charidic or glycopolysaccharidic substances in 
bacterial and fungal plant diseases has often been 
reported (Hodgson et al. 1949; Harborne, 1983, p 
743–82; Denny, 1995; van Alfen, 1989) but their 
role in the disease process is still to be clariﬁ  ed 
(Denny, 1995; van Alfen, 1989).
EPSs are considered either molecules able to 
avoid or delay the activation of plant defence, act-
ing as signal in plant pathogen cross-talk as well 
as they may have a signiﬁ  cant role in the virulence 
of the pathogen of interest. In several phytopatho-
genic bacterial species belonging to the genus 
Agrobacterium, Clavibacter, Erwinia, Pseudomo-
nas and Xanthomonas, the production of polysac-
charidic or glycopolysaccharidic substances was 
proved to be associated with water soaking and/or 
wilting symptoms and, moreover, they played an 
important role in plant colonisation by the 
bacterium (Denny, 1995). Furthermore, EPSs from 
X. campestris pv. vesicatoria were proved to induce 
phytotoxic effects (chlorosis, necrosis, electrolyte 
leakage) on the homologous host (Walkes and 
Garro, 1996).
These macromolecules appear to interfer with 
water movement in plant due to mechanical plug-
ging of the vessels which leads to wilt symptoms 
development. The phenomenon appears to be 
related to molecule size and viscosity rather than 
to their structure (Harborne, 1983, p 743–82), 
though some results on their apparent host speciﬁ  c-
ity (Rudolph et al. 1989, p 177–218) and on viscos-
ity interference (McWain and Gregory, 1972) 
would suggest a possible different behaviour in at 
least in some cases.
Lipopolysaccharides (LPSs) are complex mol-
ecules of the outer membrane of Gram negative 
bacteria containing a polysaccharide (hydrophilic) 
tail and a lipid (hydrophobic) head, which is 
anchored in the outer membrane. The molecule 
consists of three segments: lipid A, core polysac-
charide, and the antigenic O-chain. The core poly-
saccharide is further subdivided into an “inner” 
core and an “outer” core. The three segments differ 
in their composition, biosynthesis and biological 
function. Although this model of LPS was origi-
nally proposed for Salmonella spp., the basic 
features appear valid for most, if not all, Gram-
negative bacteria (Chatterjee and Vidaver, 1986, p 
94–114).
The isolation and structure determination of 
LPSs from phytopathogenic bacteria, and in par-
ticular that of the corresponding O-chain, assumed 
great importance for the possible role of this mol-
ecule in the host-pathogen interaction. LPSs appear 
to play an important role in the interaction of cells 
of pathogenic bacteria and plant and animal cell 
hosts (Medzhiton and Janway, 1997; 1998.; Dow 
et al. 2000). LPSs activate host defence systems in 
either vertebrate and invertebrate inducing the 
production of antimicrobial peptides or, in mam-
malian, that of immunoregulatory, inﬂ  ammatory 
and cytotoxic molecules. The use of mutants of 
plant pathogenic bacteria defective or lacking LPSs 
lead to assess their role in the virulence expression 
and in the recognition process which takes place 
in the ﬁ  rst phases of the interaction of the pathogen 
and plant cells.
The O-chain and lipid A, from the LPS of 
P. tolaasii, P. reactans and B. gladioli pv. 
agaricicola as well as the EPS of the latter was 
isolated and the structures determined.
Lipopolysaccharide of Pseudomonas 
tolaasii
Dried cells of type strain NCPPB2192 of P. tolaasii 
were extracted according to the water/phenol 
method (Westphal and Jann, 1965) and the LPS 
fraction was found exclusively in the phenol phase. 
The LPS material was subjected to vertical gel 
electrophoresis and it appeared as a simple ladder 
like pattern, typical of a regular repetitive lipopoly-
saccharide species of smooth LPS form. A mild acid 
hydrolysis allowed the removal of the lipid A moi-
ety by precipitation leaving the polysaccharide in 
solution which was then puriﬁ  ed by gel ﬁ  ltration. 
The compositional analysis of pure O-polysaccha-
ride, via acetylated O-methyl glycoside derivatives, 
showed the presence of 2-acetamido-2-deoxy-gulu-
ronic acid and 2-acetamido-2,6-di-deoxy-glucose 
(QuipN). Methylation analysis showed the presence 
of 3-substituted quinovosamine. The 
1H NMR spec-
trum of the polysaccharide showed in the anomeric 
region a variety of signals not all attributable to 
anomeric protons and not integrating for the same 102
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area (Fig. 17). Therefore, a detailed 2D NMR 
analysis (DQF-COSY, TOCSY, NOESY, gHSQC, 
gHMBC) allowed the complete assignment of all 
resonances. Interestingly, the HSQC spectrum 
showed the signals of some spin systems (A and A’) 
and (B and B’) and these were indicative of their 
anomeric positions.
A gHSQC spectrum registered without decou-
pling allowed the measurement of the 
1JC,H ano-
meric coupling, thus demonstrating that spin 
system A and A’ have α-conﬁ  guration whereas the 
spin system B and B’ have β-conﬁ  guration. Resi-
due A had typical proton and carbon signals of a 
uronic acid substituted at C-4 whereas residue A’ 
had proton and carbon resonances of a 4-substituted 
3-O-acetyl uronic acid. The value of the coupling 
constants and the 
13C chemical shifts were distinc-
tive of a gulo-configurated hexopyranose (De 
Castro et al. 2003). The other spin systems (B and 
B’), showing the same resonances and both char-
acterised by the anomeric signals, were identiﬁ  ed 
3-substituted β-QuipNAc. The acetyl substitution 
at C-2 of all residues and at C-3 of residue A’ was 
proven by a HMBC spectrum. The sequence of the 
monosaccharides in the repeating unit was inferred 
using interresidual NOE data measured by 2D-
NOESY and long range scalar connectivities 
measured by HMBC spectrum (Fig. 18).
Selective and milder de-O-acetylation condi-
tions were carried out (ammonium hydroxide at 
4 °C for 4 days) yielded a polysaccharide with a 
disaccharide repeating unit as demonstrated by 2D 
NMR analysis. This experiment demonstrated 
2-acetamido-2-deoxy-gulopyranuronamide and 
2-acetamido-2,6-di-deoxy-glucopyranose as 
constituents of the disaccharide unit. The absolute 
conﬁ  guration of these residues was determined by 
using both NMR and the Exciton Coupling Method 
approaches (Harada and Nakanishi, 1983) carried 
out on the corresponding p-bromobenzoyl deriva-
tives of O-methyl glycosides N-acetylated obtained 
by a strong methanolysis of O-chain followed by 
acetylation.
The absolute conﬁ  guration of both gulopyra-
nose units derivative was established on the basis 
of 
13C chemical shifts of the de-acetylated deriva-
tive. The analysis has been carried out considering 
the two possible relative conﬁ  gurations for the 
compound in the disaccharide repeating unit, that 
is: →4)-α-L-Gulp-NAcAN-(1→3)-β-D-QuipNAc-
(1→ and →4)-α-D-GulpNAcAN-(1→3)-β-D-
QuipNAc-(1→. The 
13C chemical shifts of 
Figure 17. 
1H NMR spectrum of the O-chain of the LPS from Pseudomonas tolaasii.103
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gulopyranose residue univocally indicate 
L-conﬁ  guration in agreement with previous data 
(Lipkind et al. 1988; Shashkov et al. 1988).
Hence, the O-chain of the LPS from the mush-
rooms associated bacterium P. tolaasii consists in 
a tetrasaccharide repeating unit built up of two 
units 2-acetamido-2,6-di-deoxy-glucopyranose 
and two units of   2-acetamido-2-deoxy-gulopy-
ranuronamide, one of which is acetylated at C-3 
position, as shown below:
→4)-α-L-GulpNAc3AcAN-(1→3)-β-D-QuipNAc-
(1→4)-α-L-GulpNAcAN-(1→3)-β-D-QuipNAc-
(1→ (Molinaro et al. 2003).
Lipopolysaccharide of Pseudomonas 
reactans
SDS PAGE electrophoresis of water and phenol 
extracts arising from phenol-water extraction of 
strain NCPPB1311 of P. reactans cells showed that 
only the phenol phase had the typical banding pat-
tern of smooth LPS. Methylation analysis of the 
latter fraction revealed the presence of terminal-
Glc and 4-substituted-Glc units and, furthermore, 
its 
1H NMR spectrum showed an anomeric signal 
at 5.41 ppm, as broad singlet, in addition to carbi-
nolic signals in the range 3.48–4.21 ppm. All these 
data suggested an amylose-like structure charac-
terised by an average-molecular weight of 300 KDa 
as obtained by gel-permeation cromatography.
The presence of 2-keto-3-deoxy-D-mannoocta-
noic acid (Kdo), dodecanoic acid (12:0), 
3-hydroxydecanoic acid [10:0 (3-OH)], 
3-hydroxydodecanoic acid, [12:0 (3-OH)] in the 
phenol phase conﬁ  rmed the LPS nature of this 
fraction. The mild-acid hydrolysis of the fraction 
removed, as precipitate, the lipid A moiety leaving 
in the supernatant, the saccharide part which, puri-
ﬁ  ed by gel-permeation chromatography, gave rise 
to two fractions; the one in the void volume rep-
resented the polysaccharidic part.
The GC-MS analysis of the high-molecular-
weight polymer showed the presence of GlcpNAc, 
QuipNAc4NAc, and alanine (Ala) and the D con-
ﬁ  guration of both sugar residues and the L con-
ﬁ  guration of Ala. The methylation data indicated 
the presence of 3-substituted glucosamine arising 
from Glcp2Am and the 3-substituted bacil-
losamine. The 
1H and 
13C NMR spectra (Figs. 19 
and 20) showed three anomeric signals of the same 
integral intensity, suggesting a trisaccharide repeat-
ing unit. Sugar moieties are named with A-C letters 
in order of decreasing chemical shift (Table 8).
The anomeric conﬁ  gurations, on the basis of 
their chemical shift values positively conﬁ  rmed by 
their 
3JH-H and 
1JC-H values measured from a cou-
pled HSQC experiment, were established to be α, 
α and β for A, B and C residues, respectively. The 
complete assignment of all proton and carbon 
signals was achieved by 2D homonuclear and 
heteronuclear experiments (DQF-COSY, TOCSY, 
ROESY, HSQC, HMBC). The 
13C NMR spectrum 
was also informative in showing several signals of 
carbons bearing nitrogen including two signals 
assigned to a C=N and a CH3 group, respectively, 
of an acetamidino group (Am), the presence 
of which was established by chemical and 
spectroscopic work carried out on the O-chain. The 
Figure 18. Relevant HMBC correlation of the anomeric region of the O-chain from Pseudomonas tolaasii.104
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Residue  H-1/C-1 H-2/C-2 H-3/C-3 H-4/C-4 H-5/C-5  H-6/C-6
QuipNAc4NAc  5.199 4.039 3.933 3.751 3.893  1.239
(A)  95.8 52.1 74.4 56.4 67.4  16.4
Acetyl (×2)   1.987       
 174.0  23.2       
GlcAm  4.971 4.103 3.777 3.969 3.986  3.866,  3.854
(B)  98.0 50.4 76.6 74.6 72.5  61.1
Amidino group    2.209       
 166.6  19.7       
QuipNAlaAc4NAlaAc 4.325  3.745  3.766  3.579  3.461  1.191
(C)  100.7 56.8 76.5 56.1 71.0  17.6
Ala1 residue    4.239  1.324     
 176.6  51.0  18.0     
Ala2 residue    4.099  1.274     
 177.4  51.9  17.0     
Ac Ala1    1.983       
 174.2  22.7       
Ac Ala2    1.973       
 176.3  22.8       
localisation of the acetoamidino group was inferred 
by the ROESY spectrum.
The proton and carbon signals of the two alanine 
residues (named ala1 and ala2) were clearly identi-
ﬁ  ed starting from nitrogen-bearing carbon, which 
were correlated in the HMBC with the methyl dou-
blets. Moreover, the correlations between the 
methine proton of each alanine residue with two 
carbonyl carbons, in turn correlated to methyl acetyl 
signals, indicated that both the alanine residues were 
acetylated. The location of both alanine units on the 
residue C was positively established by the observa-
tion of the connectivities observed in the HMBC 
spectrum. These data were positively conﬁ  rmed by 
NOE contacts found in the ROESY spectrum.
The other two acetyl signals present in the 
1H 
and 
13C spectra were located at C-2 and C-4 of the 
residue A on the basis of the long-range correlation 
observed in the HMBC spectrum. The sequence of 
the residues was deduced by ROESY spectrum, 
whereby each anomeric proton showed an inter-
residual contact with the corresponding proton at 
the glycosylated positions.
These data, together with the downﬁ  eld shift of 
the respective carbons and with the expected 
correlations found in the HMBC spectrum, vali-
dated the proposed structure (Table 8). The pecu-
liarity of these monosaccharides, together with 
other characteristics, will allow further insight into 
P. reactans classiﬁ  cation (Molinaro et al. 2002).
Lipid A of Pseudomonas reactans
In animal pathogenic bacteria, lipid A is the 
endotoxic portion of LPS and its conservative 
structure usually consists of a glucosamine (GlcN) 
Table 8. 
1H and 
13C NMR resonance for each residue and substituent of the O-chain from Pseudomonas reactans.105
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Figure 20. 
13C NMR spectrum of the O-chain polysacharide from Pseudomonas reactans.
Figure 19. 
1H NMR spectrum of the O-chain polysacharide from Pseudomonas reactans.106
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disaccharide backbone which is phosphorylated at 
positions 1 and 4’ and is acylated at the positions 
2, 3, 2’ and 3’ of the GlcN I (proximal) and GlcN 
II (distal) residue with 3-hydroxy fatty acids 
(Zähringer et al. 1999, p 93–114). To date, very 
little is known about the structure and functions of 
lipid A in nonanimal associated bacteria (Newmann 
et al. 2000). Moreover, the study of lipid A struc-
tures from nontoxic Gram-negative bacteria is 
extremely important in order to identify lipid A 
analogues which can antagonize the biological 
activation of competent mammalian host cells by 
lipid A. This was the case of the lipid A of 
Rhodobacter capsulatus and its synthesized 
analogue labelled as E5531 (Christ et al. 1995).
The LPS extracted from cells of strain 
NCPPB1311 of P. reactans was hydrolysed with 
AcOH or AcONa to obtain the lipid A moiety. Both 
conditions gave the same lipid A composition as 
judged by MALDI-TOF spectrometry and 
compositional analysis. Compositional analysis 
further revealed the presence of a phosphate and 
GlcN. Methylation analysis of the de-phosphorylated 
and reduced sample showed the presence of 
6-substituted GlcNol and terminal GlcN. The 
absolute conﬁ  guration of the GlcN was demonstrated 
to be D.
Fatty acid analysis revealed the presence of 
(R)-3-hydroxydodecanoic [C12:0 (3-OH)] exclu-
sively as amides and (R)-3-hydroxydecanoic 
[C10:0 (3-OH)], (S)-2-hydroxydecanoic [C12:0 
(2-OH)] and dodecanoic acid (C12:0) linked in 
ester linkage (molar ratio: GlcN, 2; phosphate, 1.6; 
fatty acids, 5.2).
The amide-linked fatty acids were identiﬁ  ed 
using MALDI-TOF of de-O-acylated lipid A show-
ing the presence of two C12:0 (3-OH) fatty acids 
at the 2 and 2’ positions of both GlcN residues and 
a peak lacking one phosphate. Fourthermore GlcN II 
unit bearing a C12:0 (3-OH) and a phosphate group 
was identiﬁ  ed. Accordingly, a nonstoichiometric 
phosphate substitution was present on the GlcN II 
residue.
The 
1H NMR spectrum was reported in 
Figure 21A. A full two-dimensional NMR analysis 
was performed (COSY, TOCSY, ROESY, HSQC). 
The NMR data were in agreement with the results 
obtained by MS. In ROESY spectrum, besides the 
expected intra-residue correlations typical of the 
β anomeric conﬁ  guration, the anomeric proton of 
GlcN II, showed inter-residue cross peaks with the 
two protons of GlcN I. These data, together with 
the downeld shift of the C-6 of GlcN I, proved 
the β (1→6) linkage between the two sugars. 
Methylation analysis conﬁ  rmed the results obtained 
by NMR.
The phosphate substitution was inferred by a 
1H, 
31P HMQC spectrum which indicated the 
anomeric α-substitution of the GlcN I and the 4’ 
substitution of the GlcN II (Fig. 21B). Therefore, 
the de-O-acylated lipid A was demonstrated to be 
composed of two D-GlcN, two units of fatty acids 
C12:0 (3-OH) N-linked to both GlcN and phosphate 
residues at position C-1 and nonstoichiometric at 
C4. A lipid A aliquot was de-phosphorylated with 
HF and the product thus obtained was analysed by 
positive ion MALDI-TOF. Some structural 
information were obtained on both a hexacyl and 
pentacyl lipid A and in particular on about the 
N-linked fatty acid distribution. Similar analyses 
were carried out on the intact lipid A and ammonium 
hydroxide treated lipid A fractions. The negative 
MALDI-TOF spectrum of intact lipid A fraction 
mainly conﬁ  rmed its fatty acid heterogeneity.
A Combination of homo- and hetero- two-
dimensional NMR experiments (COSY, TOCSY, 
ROESY, HSQC, HMBC) were performed to assign 
of the fully acetylated lipid A structure. Starting 
from the anomeric signals in the TOCSY and 
COSY spectra it was possible to identify every 
resonance of each residue.
In conclusion, the main lipid A species (Fig. 22) 
consisted of a bisphosphorylated GlcN backbone 
with phosphate groups at C-1 and at C-4’ positions 
(C-4’ phosphorylation is nonstoichiometric). Fatty 
acids are linked as amides and esters to C-2, C-3, 
Figure 21. (A) 
1H NMR spectrum and (B) 
1H, 
31P HMQC spectrum 
of de-O-acylated lipid A from Pseudomonas reactans.107
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C-2’ and C-3’, with this last carbon not always 
substituted. The hexacyl species bears two C12:0 
(3-OH) in amide linkage and two C10:0 (3-OH) in 
ester linkage; the secondary fatty acids, C12:0 
(2-OH) or C12:0, are linked to the primary C12:0 
(3-OH) amides. The pentacyl species is lacking the 
C10:0 (3-OH) at position C-3’ of distal glucos-
amine (Silipo et al. 2002).
The search for other lipid A structures of Gram-
negative bacteria is extremely important in order 
to obtain possibly non-toxic lipid A molecules 
which can act as antagonists of lipid A cell response 
and possibly prevent the septic shock in mamma-
lian cells. To the best of our knowledge this is the 
ﬁ  rst complete lipid A structure elucidated from a 
mushroom-associated bacterium, and the second 
from a nonanimal pathogenic organism, after the 
report on the lipid A structure from E. carotovora, 
a plant-associated Gram-negative bacterium 
(Fukuoka et al. 1997).
The fatty acid composition of lipid A from 
P. reactans is very close to that of other related 
Pseudomonas species in which the main molecular 
species harbour ﬁ  ve or six fatty acids (Zähringer 
et al. 1999, p 93–114). The main peculiarity is that 
in this lipid A the acyl moiety at the C-3’ position 
of GlcN II is partly missing. Actually, several 
studies have confirmed the importance of the 
structure and composition of acyl chains for 
biological activity and stimulation of mammalian 
cells. For example P. aeruginosa lipid A exhibits 
a low endotoxic activity mainly because its 
characteristic fatty acid composition lacks the 3-O-
linked fatty acid at GlcN I (Kulshin et al. 1991). 
In P. aeruginosa, Rhizobium leguminosarum and 
Salmonella typhimurium a lipase has been found 
in the external membrane that cleaves this linkage 
after complete biosynthesis of the lipid A bearing 
the two Kdo units (Basu et al. 1999; Trent et al. 
2001). In analogy, a different lipase should be 
present in the outer membrane of P. reactans, able 
to cleave selectively the ester bound fatty acid 
of the distal GlcN. The discovery of this new 
unidentified enzyme could provide a new 
biochemical apparatus for selective de-O-acylation 
and preparation of new lipid A derivatives which 
can have a different effect on immune stimulation 
in animal systems.
This chemical peculiarity in bacteria could play 
an important role in the host infection process. In 
fact, plants have been found to have systems of 
innate immunity (Newmann et al. 1997; Newmann 
et al. 1995), and it is intriguing that, in R. legumi-
nosarum, the absence of the 3-O-acyl fatty acid 
helps the bacterium to evade the host’s response 
while the plant can still defend itself from other 
Gram-negative infections (Basu et al. 1999). The 
absence of 3’-O-acyl fatty acid in the unusual lipid 
A of P. reactans might be a strategy by which the 
bacterium eludes the immune response. Further 
studies are needed to confirm this hypothesis 
(Silipo et al. 2002).
Figure 22. Structure of the main lipid A from Pseudomonas reactans.108
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Lipopolysaccharide of Burkholderia 
gladioli pv. agaricicola
A neutral O-speciﬁ  c polysaccharide (OPS) was 
obtained by mild acid hydrolysis of the lipopoly-
saccharide (LPS) of strain ICMP1096 of B. gladioli 
pv. agaricicola.
Sugar analysis of the polysaccharide identiﬁ  ed 
rhamnose, mannose and galactose in an approximate 
molar ratio of 5:2:2. Methylation analysis revealed 
the polymer to be composed of 2-substituted rham-
nopyranose and two 3- and 4-substituted hexopy-
ranose residues.
The absolute configurations of the sugars 
were identiﬁ  ed as D-mannose, D-galactose and 
D-rhamnose. The 
1H NMR spectrum (Fig. 23) of 
the O-speciﬁ  c polysaccharide contained four main 
signals in the anomeric region, a signal characteristic 
for a methyl group of rhamnose and one signal 
characteristic for an O-acetyl group. The sugar 
residues were labelled A to C according to decreas-
ing chemical shifts of the anomeric protons. The 
couplings of the anomeric signals of residues A 
and B identiﬁ  ed the manno and that of residue 
C the galacto configured residues. A COSY 
experiment allowed to locate the acetoxy group at 
C-2 of the mannose residue.
Data from sugar analysis and from NMR 
spectroscopy indicated that the OPS consisted of 
a trisaccharidic repeating unit, containing one 
residue each of D-mannose, D-rhamnose and 
D-galactose.
The complete structural characterization of the 
polysaccharide was achieved by 1D and 2D 
1H and 
13C NMR spectroscopy. 
1H,
1H COSY, double-
quantum-ﬁ  ltered COSY (DQFCOSY), ROESY 
and TOCSY, as well as 
1H,
13C HMQC and HMBC 
spectra allowed the complete assignment of all 
1H 
and 
13C chemical shifts.
The anomeric conﬁ  gurations of all residues 
were assigned by the coupling constants 
1JH-1,C-1 
which were identiﬁ  ed in another 
1H,
13C HMQC 
experiment recorded without decoupling. The 
1JH-1,C-1 revealed that the mannosyl and rhamnosyl 
residues had the α- and the galactosyl residue the 
β-anomeric conﬁ  guration.
The ROESY and 
1H,
13C HMBC experiments 
revealed the sequence of the sugar residues in the 
repeating unit.
Figure 23. 
1H NMR spectrum of the O-speciﬁ  c polysaccharide OPS of the LPS from Burkholderia gladioli pv. agaricicola.109
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In summary, the data identiﬁ  ed the structure 
of the O-speciﬁ  c polysaccharide from B. gladioli 
pv. agaricicola as:
   Ac
   ↓
   2
  →3)-α-D-Manp-(1→2)-α-D-Rhap-(1→4)-β-D-
Galp-(1→
   A  B  C
This structure was also confirmed carrying 
out similar chemical and spectroscopic studies 
on the deacetylated polysaccharide obtained by 
alkaline hydrolysis of the OPS (Karapetyan 
et al. 2006).
In conclusion, the structure of the chemical 
repeating unit of the OPS of the LPS from B. 
gladioli pv. agaricicola was established and it 
represents a novel repeating unit not found in the 
OPS of plant-pathogenic bacteria. Rhamnose is a 
common sugar in such OPS, a number of rhamnan 
backbones in OPS of LPS from plant pathogenic 
Xanthomonas and Pseudomonas species have been 
identiﬁ  ed (Knirel and Kochetkov, 1994; Jansson, 
1999, p 155–78; Corsaro et al. 2001; Evidente and 
Motta, 2002, p 581–629).
Exopolisaccharides of Burkholderia 
gladioli pv. agaricicola
A putative capsular polysaccharide containing 
D-rhamnose was isolated from cells of strain 
ICMP1096 of B. gladioli pv. agaricicola. 
The structure of the exopolysaccharide was 
determined by chemical analyses and NMR 
spectroscopy.
Sugar analyses of the polysaccharide identiﬁ  ed 
D-rhamnose as the sole constituent. The 
1H NMR 
spectrum (Fig. 24) of the capsular polysaccharide 
showed four anomeric signals and four overlapping 
methyl signals characteristic for 6-deoxy-sugars. The 
sugar residues were labelled A to D in order to 
decreasing chemical shifts of the anomeric 
protons.
The 
13C NMR spectrum contained 20 signals, 
however, since four of them possessed double 
intensity, a total of 24 carbon atoms were present, 
Figure 24. 
1H NMR spectrum of the capsular polysaccharide isolated from Burkholderia gladioli pv. agaricicola.110
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thus conﬁ  rming a repeating unit comprising four 
hexoses. A 
1H,
13C-heteronuclear multiple-quantum 
coherence (HMQC) experiment identiﬁ  ed four 
anomeric carbon signals.
The anomeric conﬁ  gurations of all rhamnose 
residues were assigned by the coupling constants 
1JH-1,C-1 which were identiﬁ  ed in another 
1H,
13C 
HMQC experiment without decoupling. The com-
plete structural characterization of the capsular 
polysaccharide was achieved by 1D and 2D 
1H and 
13C NMR spectroscopy. 
1H,
1H COSY, double-quan-
tum-ﬁ  ltered COSY (DQFCOSY) and TOCSY, as 
well as 
1H,
13C HMQC spectra allowed the complete 
assignment of all 
1H and 
13C chemical shifts.
The 2D rotating frame nuclear Overhauser 
spectroscopy (ROESY) and 
1H,
13C-heteronuclear 
multi bond correlation (HMBC) experiments 
revealed the sequence of the sugar residues in the 
repeating unit.
In summary, the data identiﬁ  ed the structure of 
a putative capsular polysaccharide from B. gladioli 
pv. agaricicola as (Kaczynsky et al. 2006):
 A   B   
→4)-α-D-Rhap-(1→3)-α-D-Rhap-(1→3)-α-D-
Rhap-(1→3)-β-D-Rhap-(1→
  C  D
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